Mirae Asset Global ETFs Holdings’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465K Sell
14,193
-412
-3% -$14.8K ﹤0.01% 2047
2026
Q1
$516K Buy
14,605
+105
+0.7% +$4.27K ﹤0.01% 1873
2025
Q4
$589K Buy
14,500
+23
+0.2% +$1K ﹤0.01% 1803
2025
Q3
$681K Sell
14,477
-2,604
-15% -$135K ﹤0.01% 1710
2025
Q2
$890K Sell
17,081
-1,273
-7% -$69.9K ﹤0.01% 1507
2025
Q1
$1.11M Buy
18,354
+800
+5% +$51.6K ﹤0.01% 1450
2024
Q4
$1.2M Buy
17,554
+664
+4% +$46.3K ﹤0.01% 1459
2024
Q3
$1.21M Buy
16,890
+620
+4% +$43.7K ﹤0.01% 1435
2024
Q2
$1.13M Buy
+16,270
New +$1.19M ﹤0.01% 1387

Other funds holding CNMD

Mirae Asset Global ETFs Holdings's CNMD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its CONMED (CNMD) stake by 2.8% in Q2 2026, selling an estimated $14.8K and leaving 14,193 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #2047.

Mirae Asset Global ETFs Holdings first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.21M in Q3 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 14,193 shares of CONMED worth $465K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 412 CONMED shares in Q2 2026, an estimated $14.8K.
  • CONMED made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2047 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's CONMED position peaked at $1.21M in Q3 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.